Drugs / limbal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04484402 | Oct 2016 → Dec 2019 | corneal dystrophy, corneal ulcer | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | limbal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04484402 ↗ |
| Modality | Cell therapy | “Autologous adipose-derived limbal stem cells” NCT04484402 ↗ |
| Route | Other | “perilimbal injections of cultured autologous stem cells are performed” NCT04484402 ↗ |